| 摘要 |
The present invention relates to novel 4,4diaryl-2-hydroxybutylamines and to a process for the preparation thereof. The new compounds exist in the free base form, as acid addition salts and quaternary ammonium salts, and exhibit antiarrhythmic activity when administed by the oral or parenteral routes. |
